De la Corte, H, Expósito, MC, De Paz, MR, Ureña, LE, Jaime, FJL, Canaro, M, Coll, J, Candel, FG, Hidalgo, O, Boix, SB, Lucas, J, Vázquez, RN, Mesa, A, Sanchez, VB, Román, TA. Enhancing Physical Activity in Patients Treated With Emicizumab in Hemophilia A: Results From the HEMO-ACT Cross-Sectional Study. HAEMOPHILIA. 2026; 32DOI:. PMID:. IF:3.000(Q2/4D).

Han, JH, ten Cate, V, Li-Gao, R, Robles, AP, Sulochana, HR, Andrade-Navarro, MA, Ao, LJ, Noordam, R, Martinez-Perez, A, Sabater-Lleal, M, Soria, JM, Souto, JC, Rosendaal, FR, Wild, PS, Vlieg, AV. Genome-wide identification of loci associated with plasma coagulation factor IX activity. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2026; 24(2)DOI:10.1016/j.jtha.2025.10.005. PMID:41161418. IF:5.000(Q1/2D).

Vallès-Cardona, G, Caixàs, A, Berges, I, Perea, G, Vilalta, N, Corripio, R. Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk. GENETICS IN MEDICINE. 2026; 28(4)DOI:10.1016/j.gim.2026.102536. PMID:41685566. IF:6.200(Q1/1D).

Rossi-Herring, G, Belmonte, T, Rivas-Urbina, A, Benitez, S, Rotllan, N, Crespo, J, Llorente-Cortes, V, Sanchez-Quesada, JL, de Gonzalo-Calvo, D. Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023; 162DOI:10.1016/j.biopha.2023.114623. PMID:37023624. IF:6.900(Q1/1D).